New HIV strategy aims to help people who inject drugs in india

NCT ID NCT05165810

Completed Disease control Sponsor: Johns Hopkins University Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether starting HIV treatment on the same day and providing care in community centers for people who inject drugs improves viral suppression. 800 participants were randomly assigned to same-day or standard treatment start, and to community or government-based care. The goal was to see if these changes help more people stay on treatment and achieve undetectable virus levels.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Same-day ART initiation and community-based HIV care
What this could lead to: If successful, this approach could make HIV treatment more accessible and effective for people who inject drugs, leading to better viral suppression and reduced transmission.
What could go wrong: This is a completed trial, but results may not apply to all settings. The interventions are behavioral, so individual adherence and local resources can affect outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV INFECTIONS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

HIV infectious disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIV INFECTIONS

Contacts and locations

Locations

POINTER study -YRGCARE

New Delhi, India

More trials for these conditions

Other studies related to the condition(s) this trial covers.